Gerresheimer AG GRRMF Stock
Gerresheimer AG Price Chart
Gerresheimer AG GRRMF Financial and Trading Overview
Gerresheimer AG stock price | 109.34 USD |
Previous Close | 96.3 USD |
Open | 120.25 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 120.25 - 120.25 USD |
52 Week Range | 48.1 - 120.25 USD |
Volume | 100 USD |
Avg. Volume | 7 USD |
Market Cap | 4.62B USD |
Beta (5Y Monthly) | 0.996551 |
PE Ratio (TTM) | 36.11111 |
EPS (TTM) | 3.56 USD |
Forward Dividend & Yield | 1.34 (1.39%) |
Ex-Dividend Date | June 8, 2023 |
1y Target Est | N/A |
GRRMF Valuation Measures
Enterprise Value | 4.3B USD |
Trailing P/E | 36.11111 |
Forward P/E | 18.996841 |
PEG Ratio (5 yr expected) | 0.91 |
Price/Sales (ttm) | 2.4238338 |
Price/Book (mrq) | 3.2892938 |
Enterprise Value/Revenue | 2.256 |
Enterprise Value/EBITDA | 12.101 |
Trading Information
Gerresheimer AG Stock Price History
Beta (5Y Monthly) | 0.996551 |
52-Week Change | 28.22% |
S&P500 52-Week Change | 20.43% |
52 Week High | 120.25 USD |
52 Week Low | 48.1 USD |
50-Day Moving Average | 96.43 USD |
200-Day Moving Average | 72.53 USD |
GRRMF Share Statistics
Avg. Volume (3 month) | 7 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 31.4M |
Float | 31.71M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 82.01% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.25 |
Trailing Annual Dividend Yield | 1.29% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.4032 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | November 30, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | November 30, 2023 |
Profitability
Profit Margin | 5.11% |
Operating Margin (ttm) | 10.29% |
Gross Margin | 30.46% |
EBITDA Margin | 18.64% |
Management Effectiveness
Return on Assets (ttm) | 3.93% |
Return on Equity (ttm) | 9.25% |
Income Statement
Revenue (ttm) | 1.9B USD |
Revenue Per Share (ttm) | 60.57 USD |
Quarterly Revenue Growth (yoy) | 23.50% |
Gross Profit (ttm) | 546.81M USD |
EBITDA | 354.96M USD |
Net Income Avi to Common (ttm) | 97.44M USD |
Diluted EPS (ttm) | 3.33 |
Quarterly Earnings Growth (yoy) | 12.30% |
Balance Sheet
Total Cash (mrq) | 104.78M USD |
Total Cash Per Share (mrq) | 3.31 USD |
Total Debt (mrq) | 1.32B USD |
Total Debt/Equity (mrq) | 111.51 USD |
Current Ratio (mrq) | 0.866 |
Book Value Per Share (mrq) | 36.558 |
Cash Flow Statement
Operating Cash Flow (ttm) | 171.02M USD |
Levered Free Cash Flow (ttm) | -42526124 USD |
Profile of Gerresheimer AG
Country | United States |
State | N/A |
City | Düsseldorf |
Address | Klaus-Bungert-Strasse 4 |
ZIP | 40468 |
Phone | 49 211 61 81 00 |
Website | https://www.gerresheimer.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 11173 |
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment platforms. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, diagnostics, medical technology, cosmetics, and food and beverage industries. The company was founded in 1864 and is based in Düsseldorf, Germany.
Q&A For Gerresheimer AG Stock
What is a current GRRMF stock price?
Gerresheimer AG GRRMF stock price today per share is 109.34 USD.
How to purchase Gerresheimer AG stock?
You can buy GRRMF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gerresheimer AG?
The stock symbol or ticker of Gerresheimer AG is GRRMF.
Which industry does the Gerresheimer AG company belong to?
The Gerresheimer AG industry is Medical Instruments & Supplies.
How many shares does Gerresheimer AG have in circulation?
The max supply of Gerresheimer AG shares is 34.54M.
What is Gerresheimer AG Price to Earnings Ratio (PE Ratio)?
Gerresheimer AG PE Ratio is 30.71348200 now.
What was Gerresheimer AG earnings per share over the trailing 12 months (TTM)?
Gerresheimer AG EPS is 3.56 USD over the trailing 12 months.
Which sector does the Gerresheimer AG company belong to?
The Gerresheimer AG sector is Healthcare.